| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcus Biosciences, Inc. | Chief Medical Officer | Common Stock | 89,647 | $2,136,288 | $23.83 | 23 Jan 2026 | Direct |
| Arcus Biosciences, Inc. | Chief Medical Officer | Stock Option (right to buy) | 96,000 | 23 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | 23 Jan 2026 | 2 | $0 | 4 | Chief Medical Officer | 26 Jan 2026, 20:21 |
| RCUS | Arcus Biosciences, Inc. | 16 Dec 2025 | 2 | -$210,144 | 4 | Chief Medical Officer | 18 Dec 2025, 17:35 |
| RCUS | Arcus Biosciences, Inc. | 10 Feb 2025 | 2 | $0 | 4 | Chief Medical Officer | 11 Feb 2025, 21:10 |
| RCUS | Arcus Biosciences, Inc. | 31 Jan 2025 | 0 | $0 | 3 | Chief Medical Officer | 11 Feb 2025, 21:10 |